| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CROHNS.2014.01.018 |
| P698 | PubMed publication ID | 24529603 |
| P50 | author | Kerenza Hood | Q56891500 |
| P2093 | author name string | John T Green | |
| James W Berrill | |||
| Mike Sadlier | |||
| P2860 | cites work | Psychological interventions for treatment of inflammatory bowel disease | Q24234176 |
| Hypnotherapy for treatment of irritable bowel syndrome | Q24243478 | ||
| The Measurement of Observer Agreement for Categorical Data | Q26778373 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| A simple index of Crohn's-disease activity | Q28259898 | ||
| A simple clinical colitis activity index | Q29028915 | ||
| Functional bowel disorders | Q29620328 | ||
| Mindfulness Training as a Clinical Intervention: A Conceptual and Empirical Review | Q30048083 | ||
| Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials | Q33788475 | ||
| Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors | Q34115993 | ||
| Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. | Q34155802 | ||
| The placebo effect in irritable bowel syndrome trials: a meta-analysis | Q34421382 | ||
| Guidelines on the irritable bowel syndrome: mechanisms and practical management. | Q34626602 | ||
| Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis | Q34657632 | ||
| Psychotherapy with chronic inflammatory bowel disease patients: a review | Q36660253 | ||
| A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis | Q36720362 | ||
| Management of stress in inflammatory bowel disease: a therapeutic option? | Q37636105 | ||
| The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis | Q37814539 | ||
| Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis | Q38038777 | ||
| Psychotherapy for inflammatory bowel disease: a review and update | Q38087144 | ||
| The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review | Q38121001 | ||
| Which patients with IBD need psychological interventions? A controlled study | Q44583992 | ||
| Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. | Q48020566 | ||
| Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial | Q48644913 | ||
| Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life | Q48654925 | ||
| A prospective population-based study of triggers of symptomatic flares in IBD. | Q48842754 | ||
| Tinnitus rehabilitation: a mindfulness meditation cognitive behavioural therapy approach | Q50457931 | ||
| Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. | Q51009678 | ||
| Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. | Q51739262 | ||
| INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. | Q53052119 | ||
| Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. | Q53264495 | ||
| European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis | Q57265399 | ||
| Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome – A randomized controlled trial | Q57396084 | ||
| P433 | issue | 9 | |
| P921 | main subject | inflammation | Q101991 |
| inflammatory bowel diseases | Q917447 | ||
| P304 | page(s) | 945-955 | |
| P577 | publication date | 2014-02-13 | |
| P1433 | published in | Journal of Crohn's and Colitis | Q15817379 |
| P1476 | title | Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels | |
| P478 | volume | 8 |
| Q40361390 | A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease. |
| Q52590894 | Behavioural medicine and gastrointestinal disorders: the promise of positive psychology. |
| Q90339285 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults |
| Q38982194 | Complementary Therapies in Inflammatory Bowel Diseases |
| Q38839757 | Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis |
| Q95591345 | Gastrointestinal pain |
| Q91521259 | Inflammatory Bowel Disease: A Stressed "Gut/Feeling" |
| Q38819677 | Mind-Body Interventions for Irritable Bowel Syndrome Patients in the Chinese Population: a Systematic Review and Meta-Analysis |
| Q33607860 | Mind-Body Interventions for Pediatric Inflammatory Bowel Disease. |
| Q30662409 | Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial |
| Q34253883 | Mindfulness-based therapies in the treatment of functional gastrointestinal disorders: a meta-analysis. |
| Q38843247 | Modifiable Environmental Factors in Inflammatory Bowel Disease |
| Q64994077 | Neonatal Maternal Deprivation Followed by Adult Stress Enhances Adrenergic Signaling to Advance Visceral Hypersensitivity. |
| Q90699508 | Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium |
| Q90674599 | Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance |
| Q44350905 | Opioid misuse in gastroenterology and non-opioid management of abdominal pain |
| Q26765219 | Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? |
| Q38248113 | Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside |
| Q30831712 | Participants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trial |
| Q47554094 | Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals |
| Q43594513 | Probiotics: a proactive approach to health. A symposium report |
| Q34549642 | Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases |
| Q30750577 | Reduced stress and inflammatory responsiveness in experienced meditators compared to a matched healthy control group |
| Q34454367 | Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases |
| Q36362690 | Systematic review: interventions for abdominal pain management in inflammatory bowel disease. |
| Q39446181 | The Influence of Motivational Interviewing on Patients With Inflammatory Bowel Disease: A Systematic Review of the Literature |
| Q55100498 | The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders. |
| Q91739350 | The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial |
| Q92252548 | The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment |
| Q26859047 | The potential role of behavioral therapies in the management of centrally mediated abdominal pain |
| Q55233736 | Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders. |
Search more.